Nipro MedicaLyte Liquid Bicarbonate Concentrate recalled for high endotoxin levels in hemodialysis concentrate
Nipro Renal Solutions USA recalled certain lots of MedicaLyte Liquid Bicarbonate Concentrate (models BC-100 and BC+201) used in hemodialysis because they contain elevated endotoxin levels. High endotoxin in dialysis concentrates can cause serious reactions during treatment.
From the FDA notice · Read the official notice ↗ · All Nipro recalls
What to do
- Check your dialysis center's supply against the affected lot numbers: BC-100 lots N4L022 and N4L037, or BC+201 lot N4L010
- Contact your dialysis center or Nipro if you have questions about whether your treatment used affected product
- Do not use recalled lots if your facility has them in stock
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
This recall covers 4 products — see all of them.
Details
- Units affected
- 3,286 cases
- Illnesses reported
- None reported
- Manufactured in
- 509 Fishing Creek Rd, Lewisberry, PA, United States
- Classification
- Class II
- Recall number
- Z-3133-2026
In the FDA's words
- Description
- MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201 Hemodialysis concentrates contain high endotoxin levels BC-100 - Lot:N4L022 (exp.11/13/2026), N4L037(exp.11/18/2026) BC+201- Lot: N4L010(exp.11/06/2026) Distribution: Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama. Affected quantity: 3,286 cases
- Hazard
- Hemodialysis concentrates contain high endotoxin levels
4 products in this recall
Nipro MedicaLyte and Citric Complete dialysis concentrates recalled for endotoxin
Nipro is recalling four hemodialysis concentrate products because they may contain high levels of endotoxin, a substance from bacteria. The recall covers about 13,000 cases and 100 drums across the US, Guatemala, and Panama, with US distribution in FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA. No injuries have been reported.
The agency lists each product separately. Check every one you might have.
- MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201 (this page)Z-3133-2026 · 3,286 cases
- MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))Z-3134-2026 · 2,327 cases
- Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25Z-3135-2026 · 7,770 cases
- Citric Complete Liquid Citric Acid Concentrate REF: LC+200-D,LC+201, LC+225(45X)Z-3136-2026 · 100 drums/1072 cases